Cross linked high amylose starch biodegradable implants for sustained delivery of Ciprofloxacin Hydrochloride

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 5, Issue 1, 2013, Pages 391-397

  Pawarashish, Y ^a   Jadhav Khanderao, R ^a   Derledeelip, V ^b  

^a MGV's Pharmacy College   (India)

^b Department of Pharmacology   (India)

Author keywords

Ciprofloxacin hydrochloride; Cross linked high amylose starch; Implant; Osteomyelitis

Indexed keywords

CIPROFLOXACIN;

ARTICLE; BIODEGRADABLE IMPLANT; COMPRESSION; CROSS LINKING; CROSSLINKED HIGH AMYLOSE STARCH BIODEGRADABLE IMPLANT; DIFFERENTIAL SCANNING CALORIMETRY; DRUG CONTENT; DRUG FORMULATION; DRUG RELEASE; DRUG STABILITY; EXCIPIENT COMPATIBILITY; FOURIER TRANSFORM INFRARED PHOTOACOUSTIC SPECTROSCOPY; IMPLANT DIAMETER; IMPLANT HARDNESS; IMPLANT THICKNESS; KINETICS; PERCENT EROSION; PHYSICAL PARAMETERS; WATER TRANSPORT;

EID: 84874530294     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Sheskey P. J. Handbook of Pharmaceutical Excipients. In: Rowe R. C., Weller P. J. Editors. 5th Ed. London Pharmaceutical Press; 2003. p. 1920-1928.
2. http://en.wikipedia.org/wiki/Corn_starch
3. http://www.elmhurst.edu/~chm/vchembook/547starch.html
4. Tanaka K. Prevention of osteomyelitis. Bioorganic Med. Chem. 2008; 16: 9217-29.
5. Werner Z., Andrez T., Peter E. O. Prosthetic-Joint Infections. N. Engl. J. Med. 2004; 351: 1645-1654.
6. Luca L., Jon T. M., Jason H. C. Osteomyelitis in Long Bones. J. Bone Joint Surg. 2004; 86: 2305-2318.
7. Wolter K. Professional Guide to Diseases. Lippincott Williams and Wilkins. 2005. Manouche T. Diagnosis and Management of Osteomyelitis. Pharmacoeconomics. 1999; 16(6): 627-647.
8. Lenaerts V., Ronald H., Elsie V. Cross-linked high amylose starch for use in controlled release pharmaceutical formulations & process for its manufacture, United States Patent- 6607748, 2003.
9. Lenaerts V., Ronald H., Elsie V. Cross linked high amylose starch for controlled release of drugs: recent advances, J. Control. Release. 53, 1998, 225-234.
10. Fernanda O. Effects of structure & modification on sustained release properties of starches, Carbohydrate Polymers. 2009; 76: 541-547.
11. Guo-xiu Xing, Shu-fen Zhang, Ben-zhi Ju, Jin-zong Yang. Study on adsorption behavior of cross-linked cationic starch maleate for chromium (VI). Carbohydrate Polymers. 2006; 66: 246-251.
12. Cyril D., Pascal D, Vincent L. Characterization of crosslinked high amylose starch matrix implants 1. In vitro release of ciprofloxacin, J. Control. Release. 2002; 82: 83-93.
13. Castro C., Sáncheza E., Delgadoa A. Soriano I. Ciprofloxacin implants for bone infection. In vitro-in vivo characterization. J. Control. Release. 2003; 93: 341-354
14. Ramana V., Nagada C., Himanja M. Design and evaluation of mucoadhesive buccal drug delivery systems containing Metoprolol. Ind. J. Pharm. Sci. 2007; 69: 515-518.
15. Nakhat P. D. Studies on buccoadhesive tablets of terbutalinesulphate. Ind. J. Pharm. Sci. 2007; 69: 505-510.
16. Schliecke G., Carsten S., Stefan F., Andreas E., Sandow J. In vitro and in vivo correlation of buserelin release from biodegradable implants using statistical moment analysis. J. Control. Release. 2004; 94: 25-37.
17. Siewert M., Shah V. P. FIP/AAPS Guidelines to Dissolution/in vitro Release Testing of Novel/Special Dosage Forms, AAPS Pharm. Sci. Tech. 2003; 4(1): 5-15.
18. Patrick L. Drug release mechanism of paclitaxel from a chitosan-lipid implant system: Effect of swelling, degradation and morphology. Euro. J. Pharm. Biopharm. 2008; 69: 149-157.
19. Adriana F. M. et al. Development and validation of a high performance liquid chromatographic method for determination of triamcinolone acetonide from polyurethaneintraocular implants, Int. J. Pharm. Pharm. Sci. 2012; 4 (4): 132-136.
20. Brito R. S., Harsha V. G., Wasim Raja., Bhaskar Reddy K., Mohanambal E. Design, characterization and in vitro evaluation of dental implants of aceclofenac sodium for periodontitis, Int. J. Pharm. Pharm. Sci. 2012; 4 (2): 142-144.